Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$586,941
-$274,685 QoQ
Shares Held
43,445
-50.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026OCCUDO QUANTITATIVE STRATEGIES LP holds $15,036,991 across 9 Drug Manufacturers - Specialty & Generic names. VTRS ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
76,747 | $9,072,262 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
152,007 | $1,889,447 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
20,161 | $1,194,942 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
31,448 | $652,860 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
20,270 | $617,829 | |
| 6 | VTRS |
Viatris Inc
This page
|
43,445 | $586,941 | |
| 7 | LQDA |
Liquidia Corp
|
13,306 | $502,168 | |
| 8 | HROW |
Harrow, Inc.
|
8,312 | $293,081 |
All Filings in VTRS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $586,941 | 43,445 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $861,626 | 87,033 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $137,548 | 15,792 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $2,322,998 | 200,086 | Shares | Sole | 2024-11-14 | |
| 2022-09-30 | $478,261 | 56,134 | Shares | Sole | 2022-11-14 | |
| 2021-12-31 | $323,705 | 23,925 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $384,630 | 28,386 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,102,416 | 77,146 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||